A groundbreaking clinical trial for colorectal cancer created and designed by Memorial Sloan Kettering Cancer Center (MSK) that garnered international headlines for its unprecedented results is now available at Lehigh Valley Topper Cancer Institute. In June 2022, the New England Journal of Medicine reported on the initial MSK study cohort – at the time, all 14 patients had a complete clinical response, meaning no tumors were detected on MRI scans. Lehigh Valley Topper Cancer Institute is now recruiting eligible patients to participate in the trial.
Oncologist Maged Khalil, MD, with Lehigh Valley Topper Cancer Institute, will serve as the physician lead for the trial at Lehigh Valley Health Network (LVHN).